Leveraging single-cell level multiplexed immunofluorescence (IF)

Characterizing the tumor microenvironment after IO biomarker targeting in clinical trials

What will be discussed?

  • Gain insight as to how Multiplexed Immunofluorescence can be Utilized to Provide a Complete View of Tumor Behavior
  • Track the Benefits of High-Order Multiplex Panels for Exploration of Immune Evasion Mechanisms
  • Preview an Example of how MultiOmyx Analysis was Used to Characterize the Biological Effects of Dual PD-1 and CXCR4 Targeting in a Clinical Trial